Innovative IOP-Independent Neuroprotection and Neuroregeneration Strategies in the Pipeline for Glaucoma
While sustained reduction of intraocular pressure (IOP) has been shown to halt and/or delay the progressive death of retinal ganglion cells (RGCs) in glaucoma, there exists great interest in the development and validation of IOP-independent therapeutic strategies for neuroprotection and/or neurorege...
Saved in:
Main Author: | James C. Tsai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2020/9329310 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IOP-lowering and neuroprotective treatment for glaucoma: reality and prospects
by: A.E. Egorov, et al.
Published: (2019-09-01) -
Prolonging IOP-lowering effect of glaucoma surgery
by: I.B. Alekseev, et al.
Published: (2019-07-01) -
IOP-lowering effect of glaucoma surgery: retrospective analysis
by: I.B. Alekseev, et al.
Published: (2020-03-01) -
IOP-lowering therapy and ocular surface in glaucoma. Part 1. The effects of drug substances of glaucoma medications on the ocular surface
by: A.V. Antonova, et al.
Published: (2020-06-01) -
IOP-lowering effect and tolerability of prostaglandin analogues in primary open-angle glaucoma and ocular hypertension as risk factors for glaucoma progression
by: A.V. Belogurova, et al.
Published: (2019-04-01)